| Biomarker ID | 1726 |
| PMID | 30516927 |
| Year | 2018 |
| Biomarker | HA: Hyaluronic acid |
| Biomarker Basis | Concentration Based (ng/mL) |
| Biomolecule | Metabolites |
| Source | Serum |
| Subjects | Humans |
| Regulation | Upregulated in PCa (PCa: 239.6 (145.1–357.7); No PCa: 150.8 (51.8–264.1)) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Prostate Cancer Vs No Prostate Cancer |
| Type of Biomarker | Diagnostic |
| Cohort | 44 prostate cancer patients and 14 controls were used in this analysis |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.004 |
| Method Used | fluorescence-based ELISA like assay |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |